atlanta glp-1 lawsuit attorneys client reviews Ozempic – July 2026 Update Gastroparesis Claims And Ozempic: What

Long-acting GLP-1RAs are synthetic peptide molecules with modifications which further improve their stability

Marston, Eastern District of Pennsylvania Number of Cases: Approximately 2,947 pending cases (and growing rapidly) Defendants: Novo Nordisk and Eli Lilly Covered Drugs: Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, Victoza, Saxenda, Trulicity Key Developments: August 15, 2025 - Landmark Ruling: Judge Marston ruled that gastroparesis claims require objective diagnostic testing (gastric emptying scan)

This personalized approach ensures that your weight loss plan is both safe and sustainable

This can cause: What to do: Increase water intake (see water section below)

As of February 2026, only Wegovy and Rybelsus are available in pill form